Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | cyclic nucleotide gated cation channel alpha 3 | 0.0055 | 0.0142 | 0.0142 |
Brugia malayi | hypothetical protein | 0.0174 | 0.0709 | 0.0709 |
Trypanosoma brucei | Flagellar Member 6 | 0.0037 | 0.0054 | 0.0054 |
Echinococcus multilocularis | hexokinase | 0.2112 | 1 | 1 |
Echinococcus granulosus | cAMP dependent protein kinase type I beta | 0.0037 | 0.0054 | 0.0054 |
Trypanosoma brucei | cyclic nucleotide-binding domain containing protein, putative | 0.0037 | 0.0054 | 0.0054 |
Loa Loa (eye worm) | hexokinase | 0.2112 | 1 | 1 |
Mycobacterium tuberculosis | Probable glutamine-transport ATP-binding protein ABC transporter GlnQ | 0.0037 | 0.0054 | 0.5 |
Echinococcus granulosus | hyperpolarization activated cyclic | 0.0055 | 0.0142 | 0.0142 |
Echinococcus multilocularis | hexokinase | 0.2112 | 1 | 1 |
Schistosoma mansoni | 60S ribosomal protein L21 | 0.0044 | 0.0088 | 0.0088 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0037 | 0.0054 | 0.0409 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0166 | 0.0675 | 0.0625 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0037 | 0.0054 | 0.5 |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0055 | 0.0142 | 0.0142 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0162 | 0.0653 | 0.0653 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0037 | 0.0054 | 0.5 |
Loa Loa (eye worm) | hexokinase type II | 0.2112 | 1 | 1 |
Echinococcus granulosus | hexokinase | 0.2112 | 1 | 1 |
Loa Loa (eye worm) | cyclic-nucleotide gated cation channel | 0.0055 | 0.0142 | 0.0088 |
Brugia malayi | Hexokinase family protein | 0.0654 | 0.301 | 0.301 |
Leishmania major | hexokinase, putative | 0.2112 | 1 | 1 |
Plasmodium falciparum | hexokinase | 0.2112 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0044 | 0.0088 | 0.0088 |
Loa Loa (eye worm) | hexokinase | 0.2112 | 1 | 1 |
Mycobacterium ulcerans | glutaminase | 0.0299 | 0.1312 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0037 | 0.0054 | 0.0054 |
Loa Loa (eye worm) | hypothetical protein | 0.0174 | 0.0709 | 0.0659 |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0037 | 0.0054 | 0.0054 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0055 | 0.0142 | 0.0142 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0049 | 0.0112 | 0.0059 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0037 | 0.0054 | 0.0409 |
Onchocerca volvulus | 0.2112 | 1 | 1 | |
Echinococcus granulosus | cGMP dependent protein kinase | 0.0037 | 0.0054 | 0.0054 |
Onchocerca volvulus | 0.2112 | 1 | 1 | |
Trichomonas vaginalis | cAMP-dependent protein kinase regulatory subunit, putative | 0.0037 | 0.0054 | 0.0409 |
Echinococcus granulosus | potassium:sodium hyperpolarization activated | 0.0055 | 0.0142 | 0.0142 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0055 | 0.0142 | 0.0142 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0045 | 0.0092 | 1 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0166 | 0.0675 | 0.0675 |
Echinococcus multilocularis | hexokinase | 0.2112 | 1 | 1 |
Echinococcus multilocularis | cyclic nucleotide gated cation channel alpha 3 | 0.0055 | 0.0142 | 0.0088 |
Schistosoma mansoni | camp-dependent protein kinase type I-beta regulatory subunit | 0.0037 | 0.0054 | 0.0054 |
Schistosoma mansoni | hyperpolarization activated cyclic nucleotide-gated potassium channel | 0.0055 | 0.0142 | 0.0142 |
Brugia malayi | cAMP-dependent protein kinase regulatory chain, putative | 0.0037 | 0.0054 | 0.0054 |
Brugia malayi | Hexokinase family protein | 0.2112 | 1 | 1 |
Echinococcus multilocularis | potassium:sodium hyperpolarization activated | 0.0055 | 0.0142 | 0.0088 |
Loa Loa (eye worm) | acetyltransferase | 0.0166 | 0.0675 | 0.0625 |
Schistosoma mansoni | camp-dependent protein kinase type I-beta regulatory subunit | 0.0037 | 0.0054 | 0.0054 |
Schistosoma mansoni | neuropathy target esterase/swiss cheese-related protein | 0.0037 | 0.0054 | 0.0054 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0081 | 0.0264 | 0.0212 |
Echinococcus granulosus | hexokinase | 0.2112 | 1 | 1 |
Toxoplasma gondii | hexokinase | 0.2112 | 1 | 1 |
Loa Loa (eye worm) | glutaminase 2 | 0.0299 | 0.1312 | 0.1265 |
Brugia malayi | hypothetical protein | 0.0134 | 0.052 | 0.052 |
Trypanosoma brucei | cAMP response protein 1, putative | 0.0037 | 0.0054 | 0.0054 |
Loa Loa (eye worm) | hexokinase | 0.1325 | 0.6228 | 0.6208 |
Echinococcus granulosus | voltage gated potassium channel | 0.0081 | 0.0264 | 0.0264 |
Brugia malayi | Cyclic-nucleotide gated cation channel, C. elegans tax-4 ortholog | 0.0037 | 0.0054 | 0.0054 |
Echinococcus granulosus | hyperpolarization activated cyclic | 0.0055 | 0.0142 | 0.0142 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0037 | 0.0054 | 0.0054 |
Trypanosoma brucei | cAMP binding protein, putative | 0.0037 | 0.0054 | 0.0054 |
Schistosoma mansoni | glutaminase | 0.0299 | 0.1312 | 0.1312 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.026 | 0.1125 | 0.8573 |
Echinococcus granulosus | cyclic nucleotide gated cation channel | 0.0055 | 0.0142 | 0.0142 |
Schistosoma mansoni | hexokinase | 0.2112 | 1 | 1 |
Schistosoma mansoni | camp-dependent protein kinase type II regulatory subunit | 0.0037 | 0.0054 | 0.0054 |
Entamoeba histolytica | hexokinase 1 | 0.2112 | 1 | 1 |
Echinococcus multilocularis | hyperpolarization activated cyclic | 0.0055 | 0.0142 | 0.0088 |
Echinococcus granulosus | cGMP dependent protein kinase 1 | 0.0037 | 0.0054 | 0.0054 |
Onchocerca volvulus | Hexokinase homolog | 0.1325 | 0.6228 | 0.6208 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0166 | 0.0675 | 0.0675 |
Loa Loa (eye worm) | hypothetical protein | 0.0672 | 0.3096 | 0.3058 |
Echinococcus multilocularis | cyclic nucleotide gated cation channel | 0.0055 | 0.0142 | 0.0088 |
Echinococcus granulosus | cAMP dependent protein kinase type II regulatory | 0.0037 | 0.0054 | 0.0054 |
Schistosoma mansoni | camp-dependent protein kinase regulatory chain | 0.0037 | 0.0054 | 0.0054 |
Trichomonas vaginalis | cAMP-dependent protein kinase type I-beta regulatory subunit, putative | 0.0037 | 0.0054 | 0.0409 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0142 | 0.0088 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0037 | 0.0054 | 0.0409 |
Entamoeba histolytica | hexokinase 2 | 0.2112 | 1 | 1 |
Echinococcus granulosus | cyclic nucleotide gated cation channel | 0.0055 | 0.0142 | 0.0142 |
Brugia malayi | glutaminase DH11.1 | 0.0299 | 0.1312 | 0.1312 |
Loa Loa (eye worm) | hexokinase | 0.0654 | 0.301 | 0.2972 |
Mycobacterium tuberculosis | Probable transcriptional regulatory protein Cmr | 0.0037 | 0.0054 | 0.5 |
Schistosoma mansoni | similar to Protein C20orf152 homolog | 0.0037 | 0.0054 | 0.0054 |
Brugia malayi | Egg laying defective protein 4 | 0.0037 | 0.0054 | 0.0054 |
Chlamydia trachomatis | cAMP-dependent protein kinase regulatory subunit | 0.0037 | 0.0054 | 0.5 |
Loa Loa (eye worm) | cyclic-nucleotide gated cation channel | 0.0055 | 0.0142 | 0.0088 |
Loa Loa (eye worm) | glutaminase | 0.0299 | 0.1312 | 0.1265 |
Brugia malayi | Hypothetical UPF0028 protein ZK370.4 in chromosome III, putative | 0.0037 | 0.0054 | 0.0054 |
Schistosoma mansoni | camp-dependent rap1 guanine-nucleotide exchange factor | 0.0037 | 0.0054 | 0.0054 |
Echinococcus granulosus | hexokinase type 2 | 0.2112 | 1 | 1 |
Echinococcus granulosus | cGMP dependent protein kinase 1 | 0.0037 | 0.0054 | 0.0054 |
Onchocerca volvulus | 0.1325 | 0.6228 | 0.6208 | |
Echinococcus multilocularis | hyperpolarization activated cyclic | 0.0055 | 0.0142 | 0.0088 |
Echinococcus granulosus | cAMP dependent protein kinase regulatory | 0.0037 | 0.0054 | 0.0054 |
Brugia malayi | Cyclic-nucleotide gated cation channel | 0.0055 | 0.0142 | 0.0142 |
Loa Loa (eye worm) | hypothetical protein | 0.0242 | 0.1036 | 0.0988 |
Trypanosoma cruzi | hexokinase, putative | 0.2112 | 1 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0049 | 0.0112 | 0.0059 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0045 | 0.0092 | 0.0039 |
Onchocerca volvulus | Huntingtin homolog | 0.0134 | 0.052 | 0.0469 |
Trypanosoma brucei | hexokinase | 0.2112 | 1 | 1 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0304 | 0.1335 | 0.1335 |
Treponema pallidum | hexokinase (hxk) | 0.2112 | 1 | 1 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0055 | 0.0142 | 0.0142 |
Mycobacterium leprae | Conserved hypothetical protein | 0.0037 | 0.0054 | 1 |
Brugia malayi | Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog | 0.0279 | 0.1213 | 0.1213 |
Loa Loa (eye worm) | hypothetical protein | 0.1441 | 0.6782 | 0.6764 |
Trypanosoma cruzi | hexokinase, putative | 0.2112 | 1 | 1 |
Mycobacterium tuberculosis | Probable conserved transmembrane protein | 0.0037 | 0.0054 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0081 | 0.0264 | 0.0264 |
Brugia malayi | Hexokinase family protein | 0.1325 | 0.6228 | 0.6228 |
Echinococcus multilocularis | voltage gated potassium channel | 0.0081 | 0.0264 | 0.0212 |
Trypanosoma brucei | cyclic nucleotide-binding domain containing protein, putative | 0.0037 | 0.0054 | 0.0054 |
Trypanosoma brucei | hexokinase | 0.2112 | 1 | 1 |
Brugia malayi | hexokinase type II | 0.0672 | 0.3096 | 0.3096 |
Brugia malayi | Voltage-gated potassium channel, EAG (KCNH1)-related. C. elegans egl-2 ortholog | 0.0081 | 0.0264 | 0.0264 |
Echinococcus multilocularis | hexokinase type 2 | 0.2112 | 1 | 1 |
Echinococcus granulosus | cyclic nucleotide gated cation channel | 0.0037 | 0.0054 | 0.0054 |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0037 | 0.0054 | 0.0054 |
Trypanosoma brucei | hexokinase, putative | 0.2112 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.0264 | 0.0212 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0081 | 0.0264 | 0.0264 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0081 | 0.0264 | 0.0264 |
Trichomonas vaginalis | glutaminase, putative | 0.0299 | 0.1312 | 1 |
Echinococcus granulosus | potassium voltage gated channel subfamily H | 0.0279 | 0.1213 | 0.1213 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0054 | 0.0054 |
Onchocerca volvulus | Huntingtin homolog | 0.0134 | 0.052 | 0.0469 |
Onchocerca volvulus | 0.0174 | 0.0709 | 0.0659 | |
Trypanosoma brucei | protein kinase A regulatory subunit | 0.0037 | 0.0054 | 0.0054 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0049 | 0.0112 | 0.0853 |
Plasmodium vivax | hexokinase, putative | 0.2112 | 1 | 1 |
Schistosoma mansoni | cyclic nucleotide-gated ion channel | 0.0037 | 0.0054 | 0.0054 |
Loa Loa (eye worm) | hypothetical protein | 0.0672 | 0.3096 | 0.3058 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0049 | 0.0112 | 0.0112 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.026 | 0.1125 | 0.8573 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.052 | 0.0469 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0049 | 0.0112 | 0.0059 |
Onchocerca volvulus | 0.2112 | 1 | 1 | |
Schistosoma mansoni | cyclic-nucleotide-gated cation channel | 0.0055 | 0.0142 | 0.0142 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0055 | 0.0142 | 0.1079 |
Schistosoma mansoni | camp-dependent protein kinase type II-alpha regulatory subunit | 0.0037 | 0.0054 | 0.0054 |
Loa Loa (eye worm) | hypothetical protein | 0.0134 | 0.052 | 0.0469 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0049 | 0.0112 | 0.0853 |
Mycobacterium tuberculosis | Probable conserved transmembrane transport protein | 0.0037 | 0.0054 | 0.5 |
Leishmania major | hexokinase, putative | 0.2112 | 1 | 1 |
Mycobacterium tuberculosis | Conserved protein | 0.0037 | 0.0054 | 0.5 |
Schistosoma mansoni | voltage-gated potassium channel | 0.0304 | 0.1335 | 0.1335 |
Loa Loa (eye worm) | voltage and ligand gated potassium channel | 0.0279 | 0.1213 | 0.1165 |
Trichomonas vaginalis | voltage and ligand gated potassium channel, putative | 0.0055 | 0.0142 | 0.1079 |
Schistosoma mansoni | neuropathy target esterase/swiss cheese-related protein | 0.0037 | 0.0054 | 0.0054 |
Echinococcus granulosus | hexokinase | 0.2112 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0037 | 0.0054 | 0.0054 |
Echinococcus multilocularis | potassium voltage gated channel subfamily H | 0.0279 | 0.1213 | 0.1165 |
Brugia malayi | N-terminal motif family protein | 0.0037 | 0.0054 | 0.0054 |
Echinococcus granulosus | patatin phospholipase domain containing protein | 0.0037 | 0.0054 | 0.0054 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.56 nM | Compound was tested for its ability to displace [3H]-DAMGO from mu opioid receptor in hartley guinea pig brain membrane in the presence of 100 nM of DAMGO | ChEMBL. | No reference |
IC50 (binding) | = 4.67 nM | Compound was tested for its ability to displace [3H]-U-69,593 from Opioid receptor kappa 1 in hartley guinea pig brain membrane in the presence of 100 nM of U-69,593 | ChEMBL. | No reference |
IC50 (binding) | = 34 nM | Compound was tested for its ability to displace [3H]-Cl-DPDPE from delta opioid receptor in hartley guinea pig brain membrane in the presence of 100 nM of DPDPE | ChEMBL. | No reference |
IC50 (binding) | = 379.5 nM | Compound was tested for its ability to displace bremazocine from Opioid receptor kappa 2 in hartley guinea pig brain membrane | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.